AstraZeneca acquires EsoBiotec in $1 bn deal

AstraZeneca acquires EsoBiotec in $1 bn deal

18 Mar 2025

British-Swedish multinational pharmaceutical and biotechnology company AstraZenica on Monday announced the acquisition of biotechnology company EsoBiotech in a $1 billion transaction

AstraZeneca starts global recall of its controversial Covid 19 vaccine

AstraZeneca starts global recall of its controversial Covid 19 vaccine

08 May 2024

Days after admitting that its Covid 19 vaccine could cause blood clot in some people, British-Swedish pharmaceutical company AstraZeneca

AstraZeneca to buy China's Gracell Biotechnologies for $1.2 bn

AstraZeneca to buy China's Gracell Biotechnologies for $1.2 bn

27 Dec 2023

Anglo-Swedish multinational pharmaceutical and biotechnology company AstraZeneca has agreed to acquire China-based Gracell Biotechnologies Inc, for about $1.2 billion.

AstraZeneca to acquire CinCor Pharma in a deal worth $1,8 bn

11 Jan 2023

AstraZeneca to acquire biotech firm TeneoTwo in a deal worth more than $1.27 billion

08 Jul 2022

AstraZeneca to acquire Alexion in a $39 bn cash-and-stock deal

23 Dec 2020

India may grant emergency use authorisation for Oxford-AstraZeneca Covid-19 vaccine: report

24 Nov 2020

AstraZeneca Covid-19 vaccine trial volunteer in Brazil dies; testing to continue

26 Oct 2020

Sun Pharma licenses AstraZeneca to sell its oncology drugs in China

06 Nov 2019

AstraZeneca and Merck claim Japanese approval for anti-cancer drug Lynparza

20 Jun 2019

Stay ahead with Informachine News Trackers! Follow your selected sources, track business news with relevant keywords, and organize seamlessly using labels and bookmarks.

Get the business updates you need, fast, focused, and tailored just for you. Save time, stay informed, and never miss a beat!

Start your free subscription today!

Latest articles on AstraZeneca from Informachine

Eneboparatide normalised serum calcium and achieved independence from active vitamin D and oral calcium supplements in 31.1% of adults with hypoparathyroidism at week 24 in CALYPSO Phase III trial

12 May 2026

Truqap recommended by FDA Advisory Committee for PTEN-deficient metastatic hormone-sensitive prostate cancer

01 May 2026

Update on FDA Advisory Committee vote on camizestrant in combination with a CDK4/6 inhibitor for advanced HR-positive breast cancer

01 May 2026

Q1 2026 results

29 Apr 2026

Breztri approved in the US for asthma as first and only triple therapy for patients 12 years of age and older

28 Apr 2026

Saphnelo approved in the US for subcutaneous self-administration as a new autoinjector for the treatment of systemic lupus erythematosus

27 Apr 2026

Ultomiris demonstrated statistically significant and clinically meaningful reduction of proteinuria in adults with immunoglobulin A nephropathy in I CAN Phase III trial

22 Apr 2026

Tozorakimab met primary endpoint in Phase III MIRANDA trial in patients with COPD

20 Apr 2026

Alexion data at 2026 AAN Annual Meeting reflects industry-leading portfolio and commitment to enhancing care across rare diseases

15 Apr 2026

Imfinzi plus Imjudo combined with lenvatinib and TACE demonstrated a statistically significant and clinically meaningful improvement in progression-free survival in embolisation-eligible unresectable liver cancer in EMERALD-3 Phase III trial

02 Apr 2026

View details about the software product Informachine News Trackers